Pfizer Limited — Important, 14-02-2025: General Updates

Mr. Sunil Lalbhai has completed his second term as an Independent Director of Pfizer Limited, effective February 13, 2025. As a result, he has stepped down from his roles as Chairman of the Stakeholders’ Relationship Committee and Risk Management Committee, as well as a member of the Audit Committee. The company expressed appreciation for his valuable contributions during his tenure. This change in leadership may prompt the company to evaluate its committee structures and seek new candidates for these pivotal roles, which could impact governance and operational strategies moving forward. Investors should monitor the company's next steps in filling these positions, as effective leadership is crucial for maintaining investor confidence and strategic direction.